focus -WSS

focus

author：leisure time 2025-10-01 10:35:47 - browse：3

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Allen Institute goes after foundational questions, CEO Costa says

WSS

Allen Institute goes after foundational questions, CEO Costa says

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Chronically ill young patients struggle to find fertility info

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Goldman Sachs launches $650M fund for life science investments

Antibiotic resistance and the global rise in human conflict

leisure time

focus

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

Stories you might have missed in 2023: health, science, medicine

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare Advantage coverage denials need scrutiny, senators say

The cancer drug shortage isn’t new — and neither are the solutions

Medicare Advantage overpayments discussion gets experts fired up

The high cost of giving birth even with insurance

Arena BioWorks launches in Cambridge to speed drug discovery

Peter Hotez and the public health issue of online harassment

Chronically ill young patients struggle to find fertility info

knowledge

AdventHealth escalates lawsuit against insurance vendor Multiplan

At JPM 2024, hospital systems pitch financial strength to investors

The biotech scorecard for Q1: 17 stock

Feng Zhang, Grail founder join forces on new gene editing startup

Male doctors called my cancer incurable. A female doctor showed it wasn't

Study suggests new cause of Down syndrome: cells linked to aging

entertainment

knowledge

hotspot

hotspot